The diagnostic efficacy of FDG-PET in the local recurrence of hilar bile duct cancer

J Hepatobiliary Pancreat Surg. 2006;13(5):403-8. doi: 10.1007/s00534-005-1086-9.

Abstract

Background/purpose: It is frequently difficult to make an accurate diagnosis of the local recurrence of hilar bile duct cancer (HBC). We assessed the efficacy of fluorodeoxyglucose-positron emission tomography (FDG-PET) in diagnosing the local recurrence of HBC.

Methods: Among 18 patients who had previously undergone resection of HBC, 5 were suspected of having a recurrence. These 5 patients were examined for recurrence by computed tomography (CT) and FDG-PET. A definitive diagnosis was determined either by pathological studies or by clinical follow-up.

Results: Whereas CT showed a recurrent mass in only 1 patient, FDG-PET revealed the high uptake of FDG in all patients. Histopathological and/or cytological examinations confirmed the local recurrence of HBC in 4 patients. One false-positive result occurred in a patient with reflux cholangitis. One patient with a recurrent tumor was followed by FDG-PET after irradiation therapy. The high level of FDG uptake, which had been seen in that patient before irradiation, completely disappeared after treatment.

Conclusions: When used in combination with other modalities, FDG-PET offered useful information for the diagnosis of a local recurrence of HBC. This highly sensitive imaging approach also appeared to be useful for follow-up examination after irradiation therapy.

MeSH terms

  • Aged
  • Bile Duct Neoplasms / diagnostic imaging*
  • Bile Duct Neoplasms / radiotherapy
  • Cholangitis / diagnostic imaging
  • Diagnosis, Differential
  • Female
  • Fluorodeoxyglucose F18*
  • Follow-Up Studies
  • Hepatic Duct, Common*
  • Humans
  • Middle Aged
  • Neoplasm Recurrence, Local
  • Positron-Emission Tomography*
  • Tomography, X-Ray Computed

Substances

  • Fluorodeoxyglucose F18